hey-Chen-Hua
    • Create new note
    • Create a note from template
      • Sharing URL Link copied
      • /edit
      • View mode
        • Edit mode
        • View mode
        • Book mode
        • Slide mode
        Edit mode View mode Book mode Slide mode
      • Customize slides
      • Note Permission
      • Read
        • Only me
        • Signed-in users
        • Everyone
        Only me Signed-in users Everyone
      • Write
        • Only me
        • Signed-in users
        • Everyone
        Only me Signed-in users Everyone
      • Engagement control Commenting, Suggest edit, Emoji Reply
    • Invite by email
      Invitee

      This note has no invitees

    • Publish Note

      Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note

      Your note will be visible on your profile and discoverable by anyone.
      Your note is now live.
      This note is visible on your profile and discoverable online.
      Everyone on the web can find and read all notes of this public team.
      See published notes
      Unpublish note
      Please check the box to agree to the Community Guidelines.
      View profile
    • Commenting
      Permission
      Disabled Forbidden Owners Signed-in users Everyone
    • Enable
    • Permission
      • Forbidden
      • Owners
      • Signed-in users
      • Everyone
    • Suggest edit
      Permission
      Disabled Forbidden Owners Signed-in users Everyone
    • Enable
    • Permission
      • Forbidden
      • Owners
      • Signed-in users
    • Emoji Reply
    • Enable
    • Versions and GitHub Sync
    • Note settings
    • Note Insights New
    • Engagement control
    • Make a copy
    • Transfer ownership
    • Delete this note
    • Save as template
    • Insert from template
    • Import from
      • Dropbox
      • Google Drive
      • Gist
      • Clipboard
    • Export to
      • Dropbox
      • Google Drive
      • Gist
    • Download
      • Markdown
      • HTML
      • Raw HTML
Menu Note settings Note Insights Versions and GitHub Sync Sharing URL Create Help
Create Create new note Create a note from template
Menu
Options
Engagement control Make a copy Transfer ownership Delete this note
Import from
Dropbox Google Drive Gist Clipboard
Export to
Dropbox Google Drive Gist
Download
Markdown HTML Raw HTML
Back
Sharing URL Link copied
/edit
View mode
  • Edit mode
  • View mode
  • Book mode
  • Slide mode
Edit mode View mode Book mode Slide mode
Customize slides
Note Permission
Read
Only me
  • Only me
  • Signed-in users
  • Everyone
Only me Signed-in users Everyone
Write
Only me
  • Only me
  • Signed-in users
  • Everyone
Only me Signed-in users Everyone
Engagement control Commenting, Suggest edit, Emoji Reply
  • Invite by email
    Invitee

    This note has no invitees

  • Publish Note

    Share your work with the world Congratulations! 🎉 Your note is out in the world Publish Note

    Your note will be visible on your profile and discoverable by anyone.
    Your note is now live.
    This note is visible on your profile and discoverable online.
    Everyone on the web can find and read all notes of this public team.
    See published notes
    Unpublish note
    Please check the box to agree to the Community Guidelines.
    View profile
    Engagement control
    Commenting
    Permission
    Disabled Forbidden Owners Signed-in users Everyone
    Enable
    Permission
    • Forbidden
    • Owners
    • Signed-in users
    • Everyone
    Suggest edit
    Permission
    Disabled Forbidden Owners Signed-in users Everyone
    Enable
    Permission
    • Forbidden
    • Owners
    • Signed-in users
    Emoji Reply
    Enable
    Import from Dropbox Google Drive Gist Clipboard
       Owned this note    Owned this note      
    Published Linked with GitHub
    • Any changes
      Be notified of any changes
    • Mention me
      Be notified of mention me
    • Unsubscribe
    # 2021/10/08 星期五值日生:Clinical problem solver episode 161- Hypoglycemia ## Case profile ### History * 19 y/o male * Underlying: sensory neuron hearing loss since birth * SSx: 2~3 days of subjective fever, upper respiratory symptoms, AMS (with eyes open but poorly responding) * Rx: LMD: sudafed (psudoephedrine) and Tamiflu * Deny similar episode before this visit * PMH: no DM, sensory neuron hearing loss since birth * Current medication: nil * denied insulin use * Family denied insulin or other hypoglycemic agent at home * Social history: deny illicit drug, tobacco, or alcohol usage; work in retail; lived with parents * Family history: no DM history ### Evaluation at ER * confusion but awake, BP 100/60mmHg, f/s 24 * Rx: -> give 2 amps D50W + 1L N/S-> mental status improved -> ER Keep D10W IVD and serum glu normal after D10W IVD D/C at evening, can eat by mouth -> Recurrent hypoglycemia (f/s 45) next morning ### Physical examination (after sugar administration) * Afebrile, BP 147/72, SaO2: 99% (RA) * General appearance: well-appearing, no acute distress, BMI: 21 * HEENT: unremarkable, no lymphadenopathy * CV: unremarkable, pectus excavatum * Chest: bilateral clear breath sound * Abd: normoactive bowel sound, non-tenderness, non-distend * Limb: no peripheral edema * Skin: no raches ### Neurological examination * Consciousness: awake, alert and oriented * Cranial nerve: intact * Extremities: freely movable ### Lab * Initial evaluation * Lab: Na 128, K 3.5, Cl 98 23, BUN11, Cr 0.65 * AST 23, ALT 13, Bil(T) 1.0, ALK-p 26 * WBC 8700, absolute Eos count 620, Hb 8.9, Plt 139000 * Urine Sulfonylurea Screen (-)(但原則上2週後才會出來XD), U/A: ketone(1+) * Further test * Morning cortisol: <5 (low), ACTH (Cortrosyn) stimulation test: Cortisol <5 * TSH: 8.97 (H); free T3: 2.4 (L); free T4: 8 (L); thyroid peroxidase antibody (-); anti-thyroglobulin (H) * ACTH: undetectable(<5); 21 hydroxylase antibody: undetectable * FSH(WNL); LH(WNL); prolactin(WNL); testosterone(WNL) * Hx: 無性腺發育異常 (pubic hair、蛋蛋大小、變聲WNL)、有鬍子(但不太需要刮)、晨勃(+) * PE: 6尺高(=182cm)(Father 5.6; 哥哥 5.7) ## Case resolution * Brain MRI: large and partially empty sella tucica (atypical for this age group), no other pituitary lesion * Diagnosis 1. Secondary adrenal insufficiency, r/o empty sella tucica related, auto-antibodies against ACTH producing cell, underlying genetic disorder (r/o Pendred syndrome: hearing loss and a thyroid condition,但不能解釋adrenal insufficiency) 2. Primary hypothyroidism * Treatment 1. Hydrocortisone 2. Levothyroxine ## Clinical pearls ### Hypoglycemia #### 最初要釐清的: 1. 知道病人有沒DM 2. 最常見住院造成hypoglycemia 1. Renal failure 2. Liver failure 3. Further exacerbated by infection #### True hypoglycemia→ Wipple triad! 1. 血糖低:有人認為定義為65以下,但對低血糖的界定仍需因個人體質而異 2. 低血糖症狀 (AMS,…) 3. 給糖水之後改善 #### Etiology ##### 病史釐清: * Hx: illicit drug (永遠抱持一顆懷疑的心) * BMI可作為營養不良的參考 * FHx: 明確釐清有其必要性,細問到底是沒有還是不確定有沒有 #### Thinking process * Insulin medicated or Non-insulin mediated * C-peptide, insulin數值在recurrent hypoglycemia後可進一步survey ### Adrenal insufficiency 1. Diagnostic test * Cortisol Random cortisol角色在於特別低可以診斷為adrenal insufficiency,但若數值borderline則較不具參考性 * ACTH (Cortrosyn) stimulation test * 不局限於早晨施作,肇因於給予的劑量遠超過生理劑量(super physiologic dosage),故在任何時間施作皆有其作用 * ACTH數值可用來鑑別central與primary adrenal insufficiency,但仍舊受限於lab無法很快得到結果。 * 另外若已知ACTH不足,則無須再驗21 hydroxylase antibody (已經證實並非primary adrenal insufficiency * ACTH test須注意準確度問題,避免lab error造成不必要intervention 2. Central adrenal insufficiency 1. TSH數值可能因此較原先低,但在此病人身上TSH數值borderline 2. 另需釐清其他賀爾蒙有無受到影響,原則上影響順序為growth hormone→生殖 (女: 月經週期、男: 性慾sexual drive、勃起、發育)→thyroid→glucocortical-axis。仍有極少數isolated pituitary loss of function,可能與IgG4相關 (目前仍證據不足) * 由此可知從簡單的history taking中詢問gonadal function對診斷治療的重要性 3. Mass effect造成的isolated adrenal insufficiency極少見,此情況可能自體免疫造成較合理 ### Hypothyroidism 1. Antibody test在安排上面的必要性可被挑戰 * 一來是佐證為Hashimoto’s disease並不會影響處置 * 二來TPO在15% general population中可見 * Thyroglobulin只用於thyroid cancer治療之後續追蹤 2. 治療hypothyroidism之前一定要先治療adrenal insufficiency!!!! 3. Central hypothyroidism時可見正常的TSH數值,肇因於TSH本身為結構複雜的化合物,所以實驗室測到其實是無作用的TSH 4. Subclinical hypothyroidism並非一定要接受治療,可以watchful waiting 5. 此case之中TSH、free T3和T4數值較無法與19歲這個年齡correlation ### Empty sella * 可能原先為pituitary adenoma (可進一步有mass effect或是根本沒症狀),後來因特殊原因pituitary gland萎縮而呈現出空空如也,像Sheehan syndrome這類型pituitary apoplexy ### Autoimmune polyendocrine syndrome * 須以更多peripheral endocrine problem作為佐證,釐清病人有無: 第一型DM、21 hydroxylase antibody ### Hashimoto’s encephalopathy * 需質疑此診斷是否真的存在,因general population有高TPO盛行率 ## Reflexion 1. 低血糖在臨床上並非少見,這集以一個特別的case呈現,讓整體evaluation完整而清楚。 2. 這集討論關於antibody的角色的部份十分有趣,有些檢查一開始被host駁斥(XD)沒有做的必要性,但當survey到後面時卻意外發現可以幫助排除其他可能狀況(如Autoimmune polyendocrine syndrome)。另外也看到國外跟國內對於做檢查的態度差異很大,在國外Host提到在抽血確診Hashimotos' disease不影響處置的狀況下他不太會抽,但在國內甚麼都馬抽抽看 3. 這個case整合性討論如何診斷內分泌疾病的過程讓我學到不少,尤其在臨床practice實用的小細節,以及各種檢體到底 to 抽 or not to 抽 (笑 ## Podcast連結 * https://clinicalproblemsolving.com/2021/02/18/episode-161-consult-question-1-hypoglycemia/

    Import from clipboard

    Paste your markdown or webpage here...

    Advanced permission required

    Your current role can only read. Ask the system administrator to acquire write and comment permission.

    This team is disabled

    Sorry, this team is disabled. You can't edit this note.

    This note is locked

    Sorry, only owner can edit this note.

    Reach the limit

    Sorry, you've reached the max length this note can be.
    Please reduce the content or divide it to more notes, thank you!

    Import from Gist

    Import from Snippet

    or

    Export to Snippet

    Are you sure?

    Do you really want to delete this note?
    All users will lose their connection.

    Create a note from template

    Create a note from template

    Oops...
    This template has been removed or transferred.
    Upgrade
    All
    • All
    • Team
    No template.

    Create a template

    Upgrade

    Delete template

    Do you really want to delete this template?
    Turn this template into a regular note and keep its content, versions, and comments.

    This page need refresh

    You have an incompatible client version.
    Refresh to update.
    New version available!
    See releases notes here
    Refresh to enjoy new features.
    Your user state has changed.
    Refresh to load new user state.

    Sign in

    Forgot password

    or

    By clicking below, you agree to our terms of service.

    Sign in via Facebook Sign in via Twitter Sign in via GitHub Sign in via Dropbox Sign in with Wallet
    Wallet ( )
    Connect another wallet

    New to HackMD? Sign up

    Help

    • English
    • 中文
    • Français
    • Deutsch
    • 日本語
    • Español
    • Català
    • Ελληνικά
    • Português
    • italiano
    • Türkçe
    • Русский
    • Nederlands
    • hrvatski jezik
    • język polski
    • Українська
    • हिन्दी
    • svenska
    • Esperanto
    • dansk

    Documents

    Help & Tutorial

    How to use Book mode

    Slide Example

    API Docs

    Edit in VSCode

    Install browser extension

    Contacts

    Feedback

    Discord

    Send us email

    Resources

    Releases

    Pricing

    Blog

    Policy

    Terms

    Privacy

    Cheatsheet

    Syntax Example Reference
    # Header Header 基本排版
    - Unordered List
    • Unordered List
    1. Ordered List
    1. Ordered List
    - [ ] Todo List
    • Todo List
    > Blockquote
    Blockquote
    **Bold font** Bold font
    *Italics font* Italics font
    ~~Strikethrough~~ Strikethrough
    19^th^ 19th
    H~2~O H2O
    ++Inserted text++ Inserted text
    ==Marked text== Marked text
    [link text](https:// "title") Link
    ![image alt](https:// "title") Image
    `Code` Code 在筆記中貼入程式碼
    ```javascript
    var i = 0;
    ```
    var i = 0;
    :smile: :smile: Emoji list
    {%youtube youtube_id %} Externals
    $L^aT_eX$ LaTeX
    :::info
    This is a alert area.
    :::

    This is a alert area.

    Versions and GitHub Sync
    Get Full History Access

    • Edit version name
    • Delete

    revision author avatar     named on  

    More Less

    Note content is identical to the latest version.
    Compare
      Choose a version
      No search result
      Version not found
    Sign in to link this note to GitHub
    Learn more
    This note is not linked with GitHub
     

    Feedback

    Submission failed, please try again

    Thanks for your support.

    On a scale of 0-10, how likely is it that you would recommend HackMD to your friends, family or business associates?

    Please give us some advice and help us improve HackMD.

     

    Thanks for your feedback

    Remove version name

    Do you want to remove this version name and description?

    Transfer ownership

    Transfer to
      Warning: is a public team. If you transfer note to this team, everyone on the web can find and read this note.

        Link with GitHub

        Please authorize HackMD on GitHub
        • Please sign in to GitHub and install the HackMD app on your GitHub repo.
        • HackMD links with GitHub through a GitHub App. You can choose which repo to install our App.
        Learn more  Sign in to GitHub

        Push the note to GitHub Push to GitHub Pull a file from GitHub

          Authorize again
         

        Choose which file to push to

        Select repo
        Refresh Authorize more repos
        Select branch
        Select file
        Select branch
        Choose version(s) to push
        • Save a new version and push
        • Choose from existing versions
        Include title and tags
        Available push count

        Pull from GitHub

         
        File from GitHub
        File from HackMD

        GitHub Link Settings

        File linked

        Linked by
        File path
        Last synced branch
        Available push count

        Danger Zone

        Unlink
        You will no longer receive notification when GitHub file changes after unlink.

        Syncing

        Push failed

        Push successfully